GANEDEN announces patents covering coffee, tea and cereal probiotic products

Ganeden
is recognized as the world's leading probiotic manufacturer and distributor. Today, the company announced a U.S. patent for the application of Bacillus coagulation in all kinds of coffee, tea and cereal foods.licensed issue of
Patent
US8697055 B2
will protect the use of all coagulated spore probiotic strains, including
Ganeden
BC
30
in coffee, tea and cereal foods.Our patent attorneys at
Mintz Levin
will continue to provide legal guidance to ensure our market dominance,"
said
David K
eller, vice president of technology operations at Ganeden
Biotech.probiotics industry is growing rapidly and there is no indication that it will slow down any time soon, and the global probiotic industry will have a market size of
31
billion by
2015 and
, of which about
90
% will come from sales of functional foods and beverages. In addition, consumer awareness is increasing,
80%
consumers believe probiotics are good for their health.
ganeden
vision of biotech companies is to allow probiotics to be ingested through everyday diets without the need for additional drug supplements. Coffee, tea and cereals are an important part of this.probiotic organisms formed by spores, such as
Ganeden
BC
30
, are the only probiotics that can withstand rigorous processing processes, especially those needed to produce hot tea, coffee and cereals. The effectiveness of these microorganisms is related to their naturally occurring layers of organic material (spores), which protect the genetic core of probiotics from destruction throughout the manufacturing process and digestive tract transmission. Non-spores form probiotics, such as Lactobacillus and Bifidobacteria, that do not form this protective layer, making them more vulnerable to damage under processing conditions."
patent continues to support our customers in their exploration of launching new brands and revolutionized existing ones,
said
Andy Lefkowitz, CEO of Ganeden

Biotech.
"
We have the
GRAS
(Safety) Waiver from the U.S.
FDA
, published
17,
studies in peer-reviewed journals, more than
,100,
patents worldwide, and are about to have the first monograph licensed by the U.S. Pharmacopeia, thus once again demonstrating our commitment to science-based probiotic innovation.About
Ganeden
Biotech Ganeden
Biotech is at the forefront of probiotic research and product development, has a rich database of published research results, and has more than
100
patents related to probiotic technology in the food, beverage, animal nutrition, and current personal care materials markets.

is known for its
Ganeden
BC
30
(GBI-30

,
6086
). The probiotic has been patented and certified by the
GRAS
of the U.S.
FDA
and is a highly stable probiotic ingredient.
Ganeden
's latest product,
Bonicel
, is the first personal care ingredient with strong technology and probiotic sources with significant anti-aging effects.